Ce contenu est réservé aux abonnés de la Revue Médicale Suisse.
Si votre login ne fonctionne pas, contactez-nous à commandes@medhyg.ch
La Revue Médicale Suisse est une revue hebdomadaire dédiée à la formation continue des médecins de premiers recours et spécialistes. L'abonnement donne accès à la revue en ligne et aux applications médicales.
1. Ahles, T.A. and A.J. Saykin,Breast Cancer Chemotherapy-Related Cognitive Dysfunction.Clinical Breast Cancer, 2002.3(Suppl. 3): p. S84-S90.
2. Bassetti, C.L., P. Calabrese, and F. Gutzwiller,Demenz – Ursachen, Verlauf und Behandlungsmöglichkeiten.Eine Schweizer Perspektive, Ligatur, Stuttgart, 2011, 2011.
3. Reisberg, B., et al.,Outcome over seven years of healthy adults with and without subjective cognitive impairment.Alzheimers Dement., 2010.6(1): p. 11-24.
4. Whooley, M., et al.,Case-finding instruments for depression. Two questions are as good as many.J Gen Intern Med., 1997.12(7): p. 439-445.
5. Barker, M.J., et al.,Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis.Archives of ClinicalNeuropsychology, 2004.19(3): p. 437-454.
6. Jorm, A.,The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review.IntPsychogeriatr, 2004.16(3): p. 275-293.
7. Geroge, L. and L. Gwyther,Caregiver well-being: A multidimensional examination of family caregivers of demented adults.Gerontologist, 1986.26: p. 253-259.
8. Chen, C., K. Leung, and C. Chen,A quick dementia screening tool for primary care physicians.Arch GerontolGeriatr, 2011.53: p. 100-103.
9. Harvey, R.J., M. Skelton-Robinson, and M.N. Rossor,The prevalence and causes of dementia in people under the age of 65 years.J Neurol Neurosurg Psychiatry, 2003.74: p. 1206-1209.
10. Lissy, F. and e. al.,Autopsy Diagnosis Alzheimer Disease: Independent reviews and clinical implications.Int. J. Geriat. Psychiatry., 1995.10: p. 505-510.
11. Fearing, M., et al.,Autopsy-confirmed Alzheimer's disease versus clinically diagnosed Alzheimer's disease in the Cache County Study on Memory and Aging: A comparison of quantitative MRI and neuropsychological findings.J Clin Exp Neuropsychol, 2007.29(5): p. 553-560.
12. Dubois, B., et al.,"The 5 words": a simple and sensitive test for the diagnosis of Alzheimer's disease.Presse Med., 2002.31: p. 1696-1699.
13. Simioni, S., et al.,Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.AIDS, 2010.24(9): p. 1243-1250.
14. Condefer, K., J. Haworth, and G. Wilcock,Clinical utility of computed tomography in the assessment of dementia: a memory clinic study. .Int J Geriatr Psychiatry, 2004.19(5): p. 414-421.
15. Gutman, B., et al.,Disease classification with hippocampal shape invariants.Hippocampus, 2009.19(6): p. 572-578.
16. Krolak-Salmon, P.,What use of biological markers for the diagnosis of Alzheimer's disease and associated disorders?PsycholNeuropsychiatrVieil., 2010.8(1): p. 25-31.
17. Coen, R., et al.,Distinguishing between patients with depression or very mild Alzheimer's disease using the Delayed-Word-Recall test.Dement GeriatrCognDisord., 1997.8(4): p. 244-247.
18. Holzer, F., et al.,Risk and benefits of disclosing a diagnosis of dementia.Rev Med Suisse, 2012.8(342): p. 1130-1134.
19. Albert, M., et al.,The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. .Alzheimers Dement, 2011.7(3): p. 270-279.
20. Yaffe, K., et al.,The Metabolic Syndrome and Development of Cognitive Impairment among Older Women.Arch Neurol, 2009.66: p. 324-328.
21. Li, G., et al.,Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.Neurology, 2007.69: p. 878-885.
22. McGuinness, B., et al.,Statins for the treatment of dementia.Cochrane Database Syst Rev., 2010.4(8): p. CD007514
23. Shepardson, N., G. Shankar, and D. Selkoe,Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.Arch Neurol., 2011.68: p. 1385-1392.
24. Cherbuin, N., et al.,Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study.Dement GeriatrCognDisord., 2009.28: p. 47-55.
25. Wilkins, C., J. Mathews, and Y. Sheline,Late life depression with cognitive impairment: evaluation and treatment.Clin Interv Aging, 2009.4: p. 51-57.
26. Monsch, A., et al.,Konsensus zur Diagnostik und Betreuung von Demenzkranken in der Schweiz.Schweizerisches Medizin Forum 2008.8(8): p. 144-149.
27. Livingston, G. and C. Katona,How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis.Int J Geriatr Psychiatry, 2000.15(3): p. 203-207.
28. Livingston, G. and C. Katona,The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis.Int J Geriatr Psychiatry, 2004.19(10): p. 919-925.
29. D’EVALUATION., C.D.L.T.R.,Réévaluation des médicaments indiqués dans le traitement symptomatique de la maladie d’Alzheimer, H.A.d. Santé, Editor 2011, Haute Autorité de Santé: France.
30. Wagner, S., et al.,Cognitive training in rehabilitation: a program to treat mild cognitive impairment.Z Gerontol Geriatr, 2009.24: p. 479-487.
31. Grossberg, G., et al.,The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panel.Prim Care Companion J Clin Psychiatry., 2010.12(1): p. PCC.09cs00833.
32. Logiudice, D., et al.,Do memory clinics improve the quality of life of carers? A randomized pilot trial.Int J Geriatr Psychiatry, 1999.14(8): p. 626-632.